Back

Monoclonal antibody-based serotyping of Listeria monocytogenes provides new insights in epidemiology and virulence

Mol, J. M. A.; Duindam, K.; Temming, A. R.; van Dalen, R.; Pannekoek, Y.; van Sorge, N. M.

2026-05-20 microbiology
10.64898/2026.05.20.726485 bioRxiv
Show abstract

ObjectivesListeria monocytogenes is an opportunistic pathogen, associated with foodborne infections that disproportionately affect newborns, elderly and immunocompromised patients. L. monocytogenes can be classified on the antigenic and related structural variation of cell-associated wall teichoic acid (WTA) molecules through conventional serotyping techniques. The WTA structure of serovars (SV) 1/2, 1/2*, 3 and 7 consists of a linear poly-ribitolphosphate (RboP) polymer either with or without decoration with rhamnose (Rha) and/or N-acetylglucosamine (GlcNAc). Of these four SVs, SV1/2 (WTA with GlcNAc and Rha) causes [~] 99% of all listeriosis cases. However, conventional serotyping cannot accurately discriminate between these four SVs, particularly SVs1/2* (WTA with Rha). MethodsHere we applied two identified monoclonal antibodies (mAb), with specificity for the RboP backbone or GlcNAc modification to develop a discriminatory serotyping scheme for SV1/2, 1/2*, 3 and 7. Isogenic mutants for the different SVs were created in L. monocytogenes SV1/2 strain EGD-e. The typing scheme was then adapted to an immnoblot assay and applied to a collection of 317 previously classified listeriosis isolates from the Netherlands Reference Laboratory for Bacterial Meningitis. ResultsBinding of the RboP-specific mAb was limited to EGD-e wild type (SV1/2), but increased significantly for isogenic EGD-e mutants representing SV1/2*, 3 and 7. In contrast, the GlcNAc-specific mAb only recognized EGD-e mutants representing SVs 1/2 and 3. The combined staining profiles of the two mAbs allowed accurate discrimination of the four SVs as verified on clinical isolates. Applying this typing scheme to 317 listeriosis isolates previously typed as SV1/2, we confirmed SV designation in >90% of isolates, but also identified SV1/2* (5.4%), SV3 (0.6%) and SV7 (0.3%) isolates. SV1/2* isolates were also identified among meningitis patients. ConclusionThe increased discriminatory capacity of L. monocytogenes serotyping provides a more detailed insight of the epidemiological landscape and the critical factors for L. monocytogenes infections.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Journal of Clinical Microbiology
120 papers in training set
Top 0.1%
41.1%
2
Microbiology Spectrum
435 papers in training set
Top 0.1%
10.5%
50% of probability mass above
3
The Journal of Infectious Diseases
182 papers in training set
Top 0.8%
4.1%
4
Journal of Infection
71 papers in training set
Top 0.7%
2.5%
5
mSystems
361 papers in training set
Top 4%
2.2%
6
PLOS ONE
4510 papers in training set
Top 46%
2.2%
7
Genome Medicine
154 papers in training set
Top 4%
1.8%
8
Transboundary and Emerging Diseases
34 papers in training set
Top 0.3%
1.8%
9
Scientific Reports
3102 papers in training set
Top 55%
1.8%
10
Nature Communications
4913 papers in training set
Top 51%
1.7%
11
BMC Infectious Diseases
118 papers in training set
Top 3%
1.5%
12
PLOS Neglected Tropical Diseases
378 papers in training set
Top 3%
1.5%
13
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 3%
1.5%
14
Frontiers in Microbiology
375 papers in training set
Top 6%
1.4%
15
International Journal of Food Microbiology
11 papers in training set
Top 0.3%
1.4%
16
Clinical Microbiology and Infection
60 papers in training set
Top 0.7%
1.3%
17
Applied and Environmental Microbiology
301 papers in training set
Top 2%
1.3%
18
Emerging Infectious Diseases
103 papers in training set
Top 2%
1.0%
19
mSphere
281 papers in training set
Top 5%
1.0%
20
Journal of Microbiological Methods
11 papers in training set
Top 0.3%
0.9%
21
European Journal of Clinical Microbiology & Infectious Diseases
15 papers in training set
Top 0.1%
0.8%
22
The Lancet Microbe
43 papers in training set
Top 1%
0.8%
23
Journal of Applied Microbiology
18 papers in training set
Top 0.4%
0.8%
24
Microbial Genomics
204 papers in training set
Top 2%
0.7%
25
mBio
750 papers in training set
Top 11%
0.7%
26
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.7%
27
Biomedicines
66 papers in training set
Top 4%
0.5%
28
The Lancet Regional Health - Americas
22 papers in training set
Top 0.5%
0.5%
29
Communications Medicine
85 papers in training set
Top 2%
0.5%
30
PLOS Biology
408 papers in training set
Top 24%
0.5%